Viewing Study NCT02963506


Ignite Creation Date: 2025-12-26 @ 4:02 PM
Ignite Modification Date: 2026-02-24 @ 8:48 AM
Study NCT ID: NCT02963506
Status: COMPLETED
Last Update Posted: 2023-06-06
First Post: 2016-11-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Sponsor:
Organization: